Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Operating Leases (2019 - 2022)

Quantum Biopharma's Operating Leases history spans 4 years, with the latest figure at $38004.0 for Q4 2022.

  • On a quarterly basis, Operating Leases fell 85.12% to $38004.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $38004.0, a 85.12% decrease, with the full-year FY2022 number at $38004.0, down 85.12% from a year prior.
  • Operating Leases hit $38004.0 in Q4 2022 for Quantum Biopharma, down from $255356.0 in the prior quarter.
  • Over the last five years, Operating Leases for QNTM hit a ceiling of $255356.0 in Q4 2021 and a floor of $38004.0 in Q4 2022.
  • Historically, Operating Leases has averaged $132604.6 across 4 years, with a median of $118529.1 in 2019.
  • Biggest five-year swings in Operating Leases: skyrocketed 102.72% in 2021 and later crashed 85.12% in 2022.
  • Tracing QNTM's Operating Leases over 4 years: stood at $111096.2 in 2019, then rose by 13.38% to $125962.0 in 2020, then skyrocketed by 102.72% to $255356.0 in 2021, then crashed by 85.12% to $38004.0 in 2022.
  • Business Quant data shows Operating Leases for QNTM at $38004.0 in Q4 2022, $255356.0 in Q4 2021, and $125962.0 in Q4 2020.